Author(s): Kulwinder Singh, Monika, Neelam Verma

Email(s): kulwinder265@gmail.com

DOI: Not Available

Address: Kulwinder Singh1*, Monika2, Neelam Verma1
1Department of Biotechnology, Punjabi University, Patiala-147002, Punjab, India.
2Department of Biotechnology, Mata Gujri College, Fatehgarh Sahib-140406, Punjab, India.
*Corresponding Author

Published In:   Volume - 7,      Issue - 5,     Year - 2014


ABSTRACT:
Arthritis is a complex disorder that comprises more than hundred distinct conditions involving damage to the joints of the body. Many mediators are known to be involved in the pathophysiology and progression of arthritis. These include cartilage-degrading enzymes, cytokines, leukotrienes (LTs), and prostaglandins (PGs). In the clinical management of osteoarthritis, the choice of drugs remains confusing and controversial. Since, their introduction, COX-II specific inhibitors have become a rapidly growing segment of the prescription drug market, especially in patients with osteoarthritis and rheumatoid arthritis. Researchers have recently focused on the potentially lethal side effects associated with their. Both NSAIDs and COX-2 inhibitors are equally effective and are associated with increased risk of GI, renal, and CV adverse effects. The COX-2 enzyme is also involved in the development of many organ systems, and its inhibition may lead to various congenital defects in neonates. Complete understanding of the patient’s comorbid conditions and concomitant medications, coupled with precise monitoring during the treatment, may help to decrease the threat of adverse effects induced by non-selective NSAIDs and selective COX-2 inhibitors.


Cite this article:
Kulwinder Singh, Monika, Neelam Verma. Gastrointestinal and Cardiovascular Risks of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Time to Translate Knowledge into Practice. Research J. Pharm. and Tech. 7(5): May, 2014; Page 575-580.


Recomonded Articles:

Author(s): Abhirup Dey, Mangala Lakshmi Ragavan, Sanjeeb Kumar Mandal, Nilanjana Das

DOI: 10.5958/0974-360X.2017.00136.6         Access: Open Access Read More

Author(s): M. Sumithra, Avantika Prabhabanik

DOI: 10.5958/0974-360X.2017.00036.1         Access: Open Access Read More

Author(s): Priya P. Munshi, D.S. Mohale, R. Akkalwar, A.V. Chandewar

DOI: Not Available         Access: Open Access Read More

Author(s): Vaseeha Banu T.S., Sandhya K.V., K.N. Jayaveera

DOI: Not Available         Access: Open Access Read More

Author(s): Swathy. S, Gheena. S, Sri Varsha. L

DOI: 10.5958/0974-360X.2015.00291.7         Access: Open Access Read More

Author(s): Sarumathy S., CH Haripriya, Muddala Vara Prasanna Rao, Gayathri K., CH Bala Sudhakar, Divya M., Shanmugasundaram P.

DOI: 10.5958/0974-360X.2015.00272.3         Access: Open Access Read More

Author(s): Tapan Kumar Giri, Saumya Mishra, Dulal Krishna Tripathi

DOI: Not Available         Access: Open Access Read More

Author(s): Kalaivanan S, Sarumathy S, Anisha Ebens J, Naresh Kumar K, Roobena Parveen A, Nasreen Ashraf M.

DOI: 10.5958/0974-360X.2017.00005.1         Access: Open Access Read More

Author(s): J. Satyanarayana, A. Pavan Kumar, V. Sai Kishore, T.E. Gopala Krishna Murthy

DOI: Not Available         Access: Open Access Read More

Author(s): Mahadeva Rao U.S., Suganya M. Utharkar, C. Shanmuga Sundaram

DOI: 10.5958/0974-360X.2015.00307.8         Access: Open Access Read More

Author(s): V. Swathi, G. Velrajan, Balasubramaniam

DOI: Not Available         Access: Open Access Read More

Author(s): Alai M.S., Shinkar D.M., Saudagar R.B.

DOI: 10.5958/0974-360X.2017.00646.1         Access: Open Access Read More

Author(s): Manju Rawat, SJ Daharwal, Deependra Singh

DOI:         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags